Literature DB >> 9933092

Neonatal colonization of rats induces immunological tolerance to bacterial antigens.

M R Karlsson1, H Kahu, L A Hanson, E Telemo, U I Dahlgren.   

Abstract

We wanted to investigate the immunological events occurring in rats intestinally colonized from birth (neonatally) or at adult age with an ovalbumin (OVA)-producing Escherichia coli O6K13 strain, carrying type 1 pili. The neonatally colonized animals responded with lower delayed type hypersensitivity (DTH) against OVA and lower levels of IgG antibodies against OVA, O6 lipopolysaccharide (LPS) and type 1 pili compared to age-matched controls. The IgG antibody response against the bystander antigen, human serum albumin (HSA), was lower in the neonatally colonized animals than in the controls co-immunized with HSA and E. coli, indicating a release of suppressive factors induced by the bacterial antigens. The adult colonized animals showed an increased DTH and antibody response against OVA after immunization. They also had high pre-immunization levels of IgG anti-O6 LPS antibodies compared to controls. However, the relative increase in IgG anti-O6 LPS antibody levels after the immunization with dead E. coli was much lower in the adult colonized animals. The present results suggest that neonatal animals develop tolerance against antigen on bacterial colonizers of the intestine. In addition, this tolerance contains components of suppression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933092     DOI: 10.1002/(SICI)1521-4141(199901)29:01<109::AID-IMMU109>3.0.CO;2-S

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  The role of gut microbiota in programming the immune phenotype.

Authors:  M Weng; W A Walker
Journal:  J Dev Orig Health Dis       Date:  2013-06       Impact factor: 2.401

Review 2.  Intestinal colonization and programming of the intestinal immune response.

Authors:  Allan Walker
Journal:  J Clin Gastroenterol       Date:  2014 Nov-Dec       Impact factor: 3.062

3.  Tolerosome-induced oral tolerance is MHC dependent.

Authors:  Sofia Ostman; Maria Taube; Esbjörn Telemo
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

4.  Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma.

Authors:  Nina Almqvist; Anna Lönnqvist; Susanne Hultkrantz; Carola Rask; Esbjörn Telemo
Journal:  Immunology       Date:  2008-03-19       Impact factor: 7.397

5.  The ratio of n-6 to n-3 fatty acids in maternal diet influences the induction of neonatal immunological tolerance to ovalbumin.

Authors:  M Korotkova; E Telemo; Y Yamashiro; L A Hanson; B Strandvik
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 6.  Early-life stress origins of gastrointestinal disease: animal models, intestinal pathophysiology, and translational implications.

Authors:  Calvin S Pohl; Julia E Medland; Adam J Moeser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-08       Impact factor: 4.052

Review 7.  From Birth to "Immunohealth," Allergies and Enterocolitis.

Authors:  Pearl D Houghteling; W Allan Walker
Journal:  J Clin Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 3.062

8.  Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization.

Authors:  Neetha Parameswaran; Devadoss John Samuvel; Ramesh Kumar; Sangeeta Thatai; Vineeta Bal; Satyajit Rath; Anna George
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse.

Authors:  C H F Hansen; L Krych; D S Nielsen; F K Vogensen; L H Hansen; S J Sørensen; K Buschard; A K Hansen
Journal:  Diabetologia       Date:  2012-05-10       Impact factor: 10.122

10.  Bystander suppression of collagen-induced arthritis in mice fed ovalbumin.

Authors:  N Fredrik Bäckström; Ulf I H Dahlgren
Journal:  Arthritis Res Ther       Date:  2004-02-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.